AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / FINANCE SERVICES
HeartSciences Inc. Common Stock
XNAS · usd
SIC 6199 · FINANCE SERVICES
FIGI BBG0185L0106
3.14▼ 0.03 (-0.95%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
3.17
Day's Range
3.07 – 3.22
52-Week Range
1.63 – 5.25
Volume
21.8K
Avg Volume
142.1K
Share Statistics
Shares Outstanding
Employees
12
Exchange
XNAS
Listed
2022-06-15
Share count as of September 11, 2026

HeartSciences Inc. Common Stock (HSCS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about HeartSciences Inc. Common Stock (HSCS)
What is HeartSciences Inc. Common Stock's Market Cap?
HeartSciences Inc. Common Stock's Market Cap is $15.1M, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's Enterprise Value?
HeartSciences Inc. Common Stock's Enterprise Value is $15.0M, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's Price / Sales?
HeartSciences Inc. Common Stock's Price / Sales is 3335.4×, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's EV / Revenue?
HeartSciences Inc. Common Stock's EV / Revenue is 3328.8×, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's EV / EBITDA?
HeartSciences Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's Revenue (TTM)?
HeartSciences Inc. Common Stock's Revenue (TTM) is $4.5K, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's Net Income (TTM)?
HeartSciences Inc. Common Stock's Net Income (TTM) is -$10.3M, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's EBITDA?
HeartSciences Inc. Common Stock's EBITDA is -$9.5M, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's Diluted EPS (TTM)?
HeartSciences Inc. Common Stock's Diluted EPS (TTM) is -2.14, based on as-reported figures from SEC (XBRL) filings.
What is HeartSciences Inc. Common Stock's EBITDA Margin?
HeartSciences Inc. Common Stock's EBITDA Margin is -209135.3%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · HSCSAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJul 31, 2026Apr 30, 2026Jan 31, 2026Oct 31, 2025Jul 31, 2025Apr 30, 2025Jan 31, 2025Oct 31, 2024Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022
Revenue
YoY growth+10.5%-100.0%——
Cost of sales
Gross margin
% of revenue63.8%——58.3%
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
% of revenue140020.5%——85771.6%
Loss from operations
% of revenue-139956.7%——-85713.2%
Other income (expense)
Interest expense
Other income
Total other expense
Net loss
% of revenue-151064.0%——-97179.4%
Net loss per share, basic and diluted (in dollars per share)